Evidence map›Paper›PMID 35595809›Full record

ArticleScientific reports2022

Differences in interaction lead to the formation of different types of insulin amyloid.

Wakako Mori, Ryosuke Kawakami, Yosuke Niko, Tomohiro Haruta, Takeshi Imamura, Kentaro Shiraki, Tamotsu Zako

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Wakako MoriDepartment of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, Japan.
Ryosuke KawakamiDepartment of Molecular Medicine for Pathogenesis, Graduate School of Medicine, Ehime University, Ehime, Japan.
Yosuke NikoResearch and Education Faculty, Multidisciplinary Science Cluster, Interdisciplinary Science Unit, Kochi University, Kochi, Japan.
Tomohiro HarutaApplication Management Department, JEOL Ltd, Tokyo, Japan.
Takeshi ImamuraDepartment of Molecular Medicine for Pathogenesis, Graduate School of Medicine, Ehime University, Ehime, Japan.
Kentaro ShirakiFaculty of Pure and Applied Sciences, University of Tsukuba, Ibaraki, Japan.
Tamotsu ZakoDepartment of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, Japan. zako.tamotsu.us@ehime-u.ac.jp.
Ehime University · JPJEOL (Japan) · JPKōchi University · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin balls, localized insulin amyloids formed at the site of repeated insulin injections in patients with diabetes, cause poor glycemic control and cytotoxicity. Our previous study has shown that insulin forms two types of amyloids; toxic amyloid formed from the intact insulin ((i)-amyloid) and less-toxic amyloid formed in the presence of the reducing reagent TCEP ((r)-amyloid), suggesting insulin amyloid polymorphism. However, the differences in the formation mechanism and cytotoxicity expression are still unclear. Herein, we demonstrate that the liquid droplets, which are stabilized by electrostatic interactions, appear only in the process of toxic (i)-amyloid formation, but not in the less-toxic (r)-amyloid formation process. The effect of various additives such as arginine, 1,6-hexanediol, and salts on amyloid formation was also examined to investigate interactions that are important for amyloid formation. Our results indicate that the maturation processes of these two amyloids were significantly different, whereas the nucleation by hydrophobic interactions was similar. These results also suggest the difference in the formation mechanism of two different insulin amyloids is attributed to the difference in the intermolecular interactions and could be correlated with the cytotoxicity.

Indexed as

AmyloidAmyloidosisInsulinAmyloidogenic ProteinsHumansHydrophobic and Hydrophilic InteractionsAmyloidAmyloidogenic ProteinsInsulin

Identifiers

PMID35595809
PMCPMC9123177
OpenAlexW4280553266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.